Valuation: Epigral Limited

Market Cap 46.58B 486M 420M 395M 359M 675M 685M 4.63B 1.82B 23.29B 1.83B 1.79B 77.59B P/E 2027 *
13.4x
P/E 2028 * 10.6x
Enterprise Value 52.49B 548M 473M 445M 405M 761M 772M 5.22B 2.05B 26.25B 2.06B 2.01B 87.45B EV / Sales 2027 *
1.7x
EV / Sales 2028 * 1.4x
Free-Float
31.14%
Yield 2027 *
0.51%
Yield 2028 * 0.51%
1 day-1.60%
1 week-2.47%
Current month-0.84%
1 month+2.63%
3 months-10.32%
6 months+7.69%
Current year-11.52%
1 week 1,075
Extreme 1075
1,125
1 month 1,042.2
Extreme 1042.2
1,214
Current year 807
Extreme 807
1,400
1 year 807
Extreme 807
1,911.6
3 years 807
Extreme 807
2,406.75
5 years 426.75
Extreme 426.75
2,406.75
10 years 387.1
Extreme 387.1
2,406.75
Manager TitleAgeSince
Chief Executive Officer 41 -
Director of Finance/CFO - 2025-11-09
Compliance Officer - 2024-04-21
Director TitleAgeSince
Director/Board Member 75 2017-05-17
Director/Board Member 43 2016-10-04
Director/Board Member 41 2017-05-17
Change 5-day change 1-year change 3-year change Capi.($)
-1.60%-2.47%-42.59%+21.73% 486M
+0.50%-1.44%+0.77%+26.93% 123B
-0.25%+5.26%+332.43%+201.20% 49.66B
-0.08%-0.12%-16.04%-43.66% 39.63B
+0.19%-3.15%+16.84%-20.19% 34.01B
+2.70%-1.01%+52.43%+72.40% 25.4B
+0.93%+2.11%+23.38%-32.92% 21.1B
-6.33%-8.67%+325.47%+609.19% 19.94B
-2.94%+5.04%+33.85%+350.81% 19.15B
-0.87%-4.44%+58.10%+234.27% 18.26B
Average -0.78%+0.87%+78.46%+141.98% 35.07B
Weighted average by Cap. -0.17%+0.08%+75.68%+100.33%

Financials

2027 *2028 *
Net sales 30.88B 322M 278M 262M 238M 448M 454M 3.07B 1.2B 15.44B 1.21B 1.18B 51.43B 37.28B 389M 336M 316M 287M 540M 548M 3.71B 1.45B 18.64B 1.46B 1.43B 62.1B
Net income 3.47B 36.17M 31.24M 29.39M 26.71M 50.24M 50.98M 345M 135M 1.73B 136M 133M 5.77B 4.4B 45.89M 39.64M 37.29M 33.89M 63.75M 64.68M 437M 171M 2.2B 172M 169M 7.32B
Net Debt 5.92B 61.75M 53.33M 50.18M 45.61M 85.78M 87.04M 589M 231M 2.96B 232M 227M 9.86B 5.49B 57.28M 49.48M 46.55M 42.31M 79.57M 80.74M 546M 214M 2.75B 215M 210M 9.14B
Logo Epigral Limited
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Employees
1,135
Date Price Change Volume
26-08-18 ₹1,079.60 -1.60% 38,584
26-08-17 ₹1,097.10 -0.12% 42,312
26-08-14 ₹1,098.40 -1.63% 88,349
26-08-13 ₹1,116.60 +1.42% 27,215
26-08-12 ₹1,101.00 -0.53% 21,285
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,079.60INR
Average target price
1,728.00INR
Spread / Average Target
+60.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EPIGRAL Stock